"Allergy, Asthma & Immunology Associates of Tampa Bay, Florida has been serving our community since 1973. Treating patients of all ages from children to adults for allergic and asthmatic diseases at our five convenient locations, our board-certified allergy and immunology specialists are dedicated to providing you and your family with comprehensive and cost-effective care. As physicians on the forefront of medical science, we offer the most innovative diagnostic and treatment methods available. Our board-certified physicians commonly treat patients experiencing asthma, hay fever, chronic cough, sinusitis, headaches, insect hypersensitivity, allergic skin problems, food allergies, pet allergies, and many other related conditions."

During the past decade, University of South Florida Asthma, Allergy & Immunology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Florida Asthma, Allergy & Immunology" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of South Florida Asthma, Allergy & Immunology" are "Angioedema" (1 trials), "Asthma" (1 trials), "Bilateral Nasal Polyposis" (1 trials), "Chronic Bronchitis" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "University of South Florida Asthma, Allergy & Immunology" in a lesser frequency.

Most popular intervention types in "University of South Florida Asthma, Allergy & Immunology" are "Drug" (3 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fluticasone Propionate" (1 trials), "Lanadelumab" (1 trials), "Placebo" (1 trials), "Salmeterol" (1 trials) and "arformoterol" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of South Florida Asthma, Allergy & Immunology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University of South Florida Asthma, Allergy & Immunology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of South Florida Asthma, Allergy & Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of South Florida Asthma, Allergy & Immunology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".